Buscar

01/07/2025 DUPILUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE AND ASTHMA CONTROL IN PATIENTS WITH AND WITHOUT COEXISTING TYPE 2 CONDITIONS: RESULTS FROM THE RAPID STUDY
Mosnaim, GS, Price, D, Côté, A, Plaza, V, Xia, CM, Awad, H, Kwah, J. DUPILUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE AND ASTHMA CONTROL IN PATIENTS WITH AND WITHOUT COEXISTING TYPE 2 CONDITIONS: RESULTS FROM THE RAPID STUDY. VALUE IN HEALTH. 2025; 28(6)DOI:. PMID:. IF:6.000(Q1/1D).
01/05/2025 Real-World Evidence for Fixed Triple Therapy With Beclomethasone/Formoterol/Glycopyrronium in Asthma Patients With Concomitant COPD: Six-Month Results of Trimaximize
Gessner, C, Bogoevska,, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Fritz, C, Hahn, A, Trinkmann, F. Real-World Evidence for Fixed Triple Therapy With Beclomethasone/Formoterol/Glycopyrronium in Asthma Patients With Concomitant COPD: Six-Month Results of Trimaximize. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A3500. PMID:. IF:19.400(Q1/1D).
01/05/2025 Mortality Predictors in Thoracic Sarcoidosis: Results From SARCO-1 Registry
Torres, JS, Ramos, D, Francesqui, J, De Miguel, EB, Villar, A, Florez, P, Balcells, E, Pinillos-Robles, E, Castaño, G, Mayoral, RG, Muñiz, BL, Soler-Sampere, M, Castillo, D, Rafecas-Codern, A, Mariscal, P, Millan-Billi, P, Portillo, K, Hernandez, F. Mortality Predictors in Thoracic Sarcoidosis: Results From SARCO-1 Registry. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A1842. PMID:. IF:19.400(Q1/1D).
01/05/2025 Phenotype Analysis of Chronic Bronchial Infection Patients on Nebulized Antibiotic Therapy: A Multicenter Retrospective Cohort Study in Spain (INBREATHING Study)
Gonzalez, J, Moreno, BR, Benítez, I, Erro, M, Burgos, J, Sayés, A, García, EJ, Pou, C, Castañon, R, Navarro, A, de las Uentes, AM, Lakhani, JS, Hernández, A, Manzano, C, Santisteve, S, Monge, A, Moix, AM, Sánchez-Cucó, A, Alcaide, A, Tajos, JD, Barbe, F, Suárez, G, de la Rosa, D. Phenotype Analysis of Chronic Bronchial Infection Patients on Nebulized Antibiotic Therapy: A Multicenter Retrospective Cohort Study in Spain (INBREATHING Study). AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A5149. PMID:. IF:19.400(Q1/1D).
01/05/2025 Dupilumab Improves Health-related Quality of Life and Asthma Control in Patients With and Without Coexisting Type 2 Conditions: Results From the RAPID Study
Cote, A, Mosnaim, GS, Lugogo, NL, Price, D, Plaza, V, Changming, X, Awad, H, Kwah, J. Dupilumab Improves Health-related Quality of Life and Asthma Control in Patients With and Without Coexisting Type 2 Conditions: Results From the RAPID Study. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A1399. PMID:. IF:19.400(Q1/1D).
01/04/2025 Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry
Oscullo, G, Méndez, R, Olveira, C, Girón, R, García-Clemente, M, Máiz, L, Sibila, O, Golpe, R, Rodríguez-Hermosa, J, Barreiro, E, Prados, C, Rodríguez-López, JL, de la Rosa-carrillo, D, Martinez-García, MA. Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(4)DOI:10.1016/j.arbres.2025.02.015. PMID:40180519. IF:9.200(Q1/1D).
01/04/2025 Unraveling the Molecular Mechanisms of OSA-Related Cardiovascular Event Recurrence: A Post Hoc Analysis From the ISAACC Study
Zapater, A, Pinilla, L, Gracia-Lavedan, E, Targa, A, Torres, G, Mínguez, O, Pascual, L, Cortijo, A, Martínez, D, Benítez, ID, García-Hidalgo, MC, De Batlle, J, Abad, J, Duran-Cantolla, J, Urrutia, A, Mediano, O, Masdeu, MJ, Ordax-Carbajo, E, Masa, JF, De la Peña, M, Mayos, M, Coloma, R, Montserrat, JM, Chiner, E, Roncero, A, Sanz-Rubio, D, Barbé, F, Sánchez-de-la-Torre, M. Unraveling the Molecular Mechanisms of OSA-Related Cardiovascular Event Recurrence: A Post Hoc Analysis From the ISAACC Study. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(4)DOI:10.1016/j.arbres.2024.09.008. PMID:39438203. IF:9.200(Q1/1D).
01/04/2025 Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial
Bermudo-Peloche, G, Del Rio, B, Vicens-Zygmunt, V, Bordas-Martinez, J, Hernández, M, Valenzuela, C, Laporta, R, Bobillo, JR, Portillo, K, Millán-Billi, P, Balcells, E, Badenes-Bonet, D, Bolivar, S, Rodríguez-Portal, JA, Ramirez, CL, Tomás, L, Roitegi, KFD, Sellarés, J, Castillo, D, González, J, Barril, S, Gutiérrez-Rodríguez, Y, Caballero, P, Alarcon, J, Peñafiel, J, Sanz-Santos, J, Blavia, R, Caupena, C, Segovia, P, Santos-Pérez, S, Ferrer-Artola, A, Badia, MB, Hereu, P, Fuentes, M, Montes-Worboys, A, Franquet, T, Luburich, P, Molina-Molina, M. Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial. EUROPEAN RESPIRATORY JOURNAL. 2025; 65(4)DOI:10.1183/13993003.02249-2024. PMID:40154560. IF:21.000(Q1/1D).